Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.52%. A quarter ago, it was expected that this tissue analysis provider would post a loss of $0.37 per share when it actually produced a loss of $0.26, delivering a surprise of 29.73%.Over the last four quarters, the c ...